Trials / Completed
CompletedNCT03443804
To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients
A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase 3 Clinical Trial to Evaluated the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 462 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test(DW1401) | DW1401+Placebo of Stillen tab. |
| DRUG | Reference(Stillen tab.) | Stillen tab.+Placebo of DW1401 |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2018-02-23
- Last updated
- 2018-02-28
Source: ClinicalTrials.gov record NCT03443804. Inclusion in this directory is not an endorsement.